Skip to main content

Advertisement

Log in

Human immunodeficiency virus-related retinal microangiopathy and systemic cytomegalovirus disease association

  • Clinical Investigation
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

An Erratum to this article was published on 20 August 2013

Abstract

Purpose

To determine whether there is a significant association between human immunodeficiency virus (HIV)-related retinal microangiopathy and systemic cytomegalovirus (CMV) disease in HIV-infected patients.

Methods

Participants in this single-center, cross-sectional, retrospective study were 383 HIV-infected patients assessed for ocular manifestations before the beginning of antiretroviral therapy. The presence of HIV-related retinal microangiopathy, the presence of systemic CMV disease, laboratory data, and demographic information were determined by referring to medical records. The significance of any association between HIV-related retinal microangiopathy and systemic CMV disease was determined by use of the Chi-squared test and by multivariate analysis.

Results

HIV-related retinal microangiopathy was present in 85 patients, and was significantly associated with systemic CMV disease both by use of the Chi-squared test (P = 0.006) and by multivariate analysis (P = 0.045, odds ratio 2.03, 95 % confidence interval 1.02–4.06 adjusted for CD4+ cell count and plasma HIV-RNA level).

Conclusions

These findings indicate that microangiopathy may be involved in the development of CMV disease in HIV-infected patients. Thus, detection of the presence of HIV-related retinal microangiopathy is important in the management of HIV-infected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jabs DA, Quinn TC. Acquired immunodeficiency syndrome. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular infection and immunity. 1st ed. St. Louis, MO: Mosby-Year Book Inc.; 1996. p. 289–310.

    Google Scholar 

  2. Furrer H, Barloggio A, Egger M, Garweg JG, Swiss HIV Cohort Study. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma. Ophthalmology. 2003;110:432–6.

    Article  PubMed  Google Scholar 

  3. Spaide RF, Gaissinger A, Podhorzer JR. Risk factors for cotton-wool spots and for cytomegalovirus retinitis in patients with human immunodeficiency virus infection. Ophthalmology. 1995;102:1860–4.

    PubMed  CAS  Google Scholar 

  4. Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY. Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology. 1985;92:472–84.

    PubMed  CAS  Google Scholar 

  5. Newsome DA, Green WR, Miller ED, Kiessling LA, Morgan B, Jabs DA, et al. Microvascular aspects of acquired immune deficiency syndrome retinopathy. Am J Ophthalmol. 1984;98:590–601.

    PubMed  CAS  Google Scholar 

  6. Holland GN, Pepose JS, Pettit TH, Gottlieb MS, Yee RD, Foos RY. Acquired immune deficiency syndrome: ocular manifestations. Ophthalmology. 1983;90:859–73.

    PubMed  CAS  Google Scholar 

  7. Hodge WG, Boivin JF, Shapiro SH, Lalonde RG, Shah KC, Murphy BD, et al. Clinical risk factors for cytomegalovirus retinitis in patients with AIDS. Ophthalmology. 2004;111:1326–33.

    Article  PubMed  Google Scholar 

  8. Holland GN. AIDS and ophthalmology: the first quarter century. Am J Ophthalmol. 2008;145:397–408.

    Article  PubMed  Google Scholar 

  9. Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL. Studies of the Ocular Complications of AIDS Research Group. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2012;153:1016–24.

    Article  PubMed  Google Scholar 

  10. Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT. Centers for Disease Control and Prevention (CDC). Revised surveillance case definitions for HIV Infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years—United States, 2008. MMWR Recomm Rep. 2008;57:1–12.

    PubMed  Google Scholar 

  11. Holland GN, Tufail A, Jordan MC. Cytomegalovirus Disease. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular infection and immunity. 1st ed. St. Louis, MO: Mosby-Year Book Inc.; 1996. p. 1088–128.

    Google Scholar 

  12. Freeman WR, Chen A, Henderly DE, Levine AM, Luttrull JK, Urrea PT, et al. Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol. 1989;107:229–35.

    PubMed  CAS  Google Scholar 

  13. Lai TY, Wong RL, Luk FO, Chow VW, Chan CK, Lam DS. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era. Clin Exp Ophthalmol. 2011;39:99–104.

    Article  Google Scholar 

  14. Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990;322:166–72.

    Article  PubMed  CAS  Google Scholar 

  15. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272:1167–70.

    Article  PubMed  CAS  Google Scholar 

  16. Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, et al. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA. 1999;282:2220–6.

    Article  PubMed  CAS  Google Scholar 

  17. Mofenson LM, Harris DR, Rich K, Meyer WA 3rd, Read JS, Moye J Jr, et al. Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. AIDS. 1999;13:31–9.

    Article  PubMed  CAS  Google Scholar 

  18. Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med. 1996;124:633–42.

    Article  PubMed  CAS  Google Scholar 

  19. Mansour AM, Jampol LM, Logani S, Read J, Henderly D. Cotton-wool spots in acquired immunodeficiency syndrome compared with diabetes mellitus, systemic hypertension, and central retinal vein occlusion. Arch Ophthalmol. 1988;106:1074–7.

    Article  PubMed  CAS  Google Scholar 

  20. Santos R, Barojas E, Alarcón-Segovia D, Ibáñez G. Retinal microangiopathy in systemic lupus erythematosus. Am J Ophthalmol. 1975;80:249–52.

    PubMed  CAS  Google Scholar 

  21. Imesch PD, Bindley CD, Wallow IH. Clinicopathologic correlation of intraretinal microvascular abnormalities. Retina. 1997;17:321–9.

    Article  PubMed  CAS  Google Scholar 

  22. Estacio RO, McFarling E, Biggerstaff S, Jeffers BW, Johnson D, Schrier RW. Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am J Kidney Dis. 1998;31:947–53.

    Article  PubMed  CAS  Google Scholar 

  23. Geier SA, Schielke E, Tatsch K, Sadri I, Bogner JR, Hammel G, et al. Brain HMPAO-SPECT and ocular microangiopathic syndrome in HIV-1-infected patients. AIDS. 1993;7:1589–94.

    Article  PubMed  CAS  Google Scholar 

  24. Obel N, Thomsen HF, Kronborg G, Larsen CS, Hildebrandt PR, Sørensen HT, et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis. 2007;44:1625–31.

    Article  PubMed  Google Scholar 

  25. Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, et al. Coronary Heart Disease in HIV-Infected Individuals. J Acquir Immune Defic Syndr. 2003;33:506–12.

    Article  PubMed  Google Scholar 

  26. Chow FC, Regan S, Feske S, Meigs JB, Grinspoon SK, Triant VA. Comparison of ischemic stroke incidence in HIV-Infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr. 2012;60:351–8.

    Article  PubMed  Google Scholar 

  27. Becker S, Fusco G, Fusco J, Balu R, Gangjee S, Brennan C, Collaborations in HIV Outcomes Research/US Cohort, et al. HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: an observational study. Clin Infect Dis. 2004;39(Suppl5):S267–75.

    Article  PubMed  Google Scholar 

  28. Faber DW, Wiley CA, Lynn GB, Gross JG, Freeman WR. Role of HIV and CMV in the pathogenesis of retinitis and retinal vasculopathy in AIDS patients. Invest Ophthalmol Vis Sci. 1992;33:2345–53.

    PubMed  CAS  Google Scholar 

  29. Jabs DA. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome—bench to bedside: LXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2011;151:198–216.

    Article  PubMed  Google Scholar 

  30. Kuppermann BD, Petty JG, Richman DD, Mathews WC, Fullerton SC, Rickman LS, et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;115:575–82.

    PubMed  CAS  Google Scholar 

  31. Erice A, Tierney C, Hirsch M, Caliendo AM, Weinberg A, Kendall MA, AIDS Clinical Trials Group Protocol 360 Study Team, et al. Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360). Clin Infect Dis. 2003;37:567–78.

    Article  PubMed  CAS  Google Scholar 

  32. Williams PL, Currier JS, Swindells S. Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections. AIDS. 1999;13:1035–44.

    Article  PubMed  CAS  Google Scholar 

  33. Lyles RH, Chu C, Mellors JW, Margolick JB, Detels R, Giorgi JV, et al. Prognostic value of plasma HIV RNA in the natural history of Pneumocystis carinii pneumonia, cytomegalovirus and Mycobacterium avium complex. Multicenter AIDS Cohort Study. AIDS. 1999;13:341–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Drs. Akifumi Imamura, Akihiko Suganuma, and Naoki Yanagisawa for proofreading and data management.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuko Iwasaki.

About this article

Cite this article

Iwasaki, Y., Yamamoto, N., Kawaguchi, T. et al. Human immunodeficiency virus-related retinal microangiopathy and systemic cytomegalovirus disease association . Jpn J Ophthalmol 57, 372–378 (2013). https://doi.org/10.1007/s10384-013-0247-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-013-0247-7

Keywords

Navigation